Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society
Andrew M.D. Wolf,Elizabeth T. H. Fontham,Timothy R. Church,Christopher R. Flowers,Carmen Guerra,Samuel J. LaMonte,Ruth Etzioni,Matthew T. McKenna,Kevin C. Oeffinger,Ya Chen Tina Shih,Louise C. Walter,Kimberly S. Andrews,Otis W. Brawley,Durado Brooks,Stacey A. Fedewa,Deana Manassaram-Baptiste,Rebecca L. Siegel,Richard C. Wender,Robert A. Smith +18 more
Reads0
Chats0
TLDR
This guideline update used an existing systematic evidence review of the CRC screening literature and microsimulation modeling analyses, including a new evaluation of the age to begin screening by race and sex and additional modeling that incorporates changes in US CRC incidence.Abstract:
In the United States, colorectal cancer (CRC) is the fourth most common cancer diagnosed among adults and the second leading cause of death from cancer. For this guideline update, the American Cancer Society (ACS) used an existing systematic evidence review of the CRC screening literature and microsimulation modeling analyses, including a new evaluation of the age to begin screening by race and sex and additional modeling that incorporates changes in US CRC incidence. Screening with any one of multiple options is associated with a significant reduction in CRC incidence through the detection and removal of adenomatous polyps and other precancerous lesions and with a reduction in mortality through incidence reduction and early detection of CRC. Results from modeling analyses identified efficient and model-recommendable strategies that started screening at age 45 years. The ACS Guideline Development Group applied the Grades of Recommendations, Assessment, Development, and Evaluation (GRADE) criteria in developing and rating the recommendations. The ACS recommends that adults aged 45 years and older with an average risk of CRC undergo regular screening with either a high-sensitivity stool-based test or a structural (visual) examination, depending on patient preference and test availability. As a part of the screening process, all positive results on noncolonoscopy screening tests should be followed up with timely colonoscopy. The recommendation to begin screening at age 45 years is a qualified recommendation. The recommendation for regular screening in adults aged 50 years and older is a strong recommendation. The ACS recommends (qualified recommendations) that: 1) average-risk adults in good health with a life expectancy of more than 10 years continue CRC screening through the age of 75 years; 2) clinicians individualize CRC screening decisions for individuals aged 76 through 85 years based on patient preferences, life expectancy, health status, and prior screening history; and 3) clinicians discourage individuals older than 85 years from continuing CRC screening. The options for CRC screening are: fecal immunochemical test annually; high-sensitivity, guaiac-based fecal occult blood test annually; multitarget stool DNA test every 3 years; colonoscopy every 10 years; computed tomography colonography every 5 years; and flexible sigmoidoscopy every 5 years. CA Cancer J Clin 2018;68:250-281. © 2018 American Cancer Society.read more
Citations
More filters
Journal ArticleDOI
Clinico-pathological characteristics of obstructing colorectal cancer and its management outcomes at a tertiary referral center of Eastern Nepal
TL;DR: In this paper , the authors explored the treatment strategies being followed for patients with obstructing colorectal cancer (OCRC) at their institute and to know the management outcomes, which was found to be common in rural areas of the eastern Nepal, 16(57%) patients from such areas.
Journal ArticleDOI
Psychometric properties of a Chinese version of four-factor colorectal cancer screening belief scale
TL;DR: Wang et al. as mentioned in this paper tested the psychometric properties of a Chinese version of the four-factor CRC screening belief scale, including perceived barriers, perceived benefits, self-efficacy, and optimism.
Journal ArticleDOI
Diversin upregulates the proliferative ability of colorectal cancer by inducing cell cycle proteins.
TL;DR: In this article , diversin was found to increase the proliferation of colorectal cancer cells through the G1-S checkpoint and JNK signalling pathway, and the results indicated that diversin contributes to CRC proliferation that involves the distribution of the cell cycle.
Journal ArticleDOI
Malignant and premalignant colorectal lesions in the 40s: The new generation to be screened?
Ana Luísa Santos,Armando Peixoto,Marco Silva,Pedro Costa-Moreira,Rosa Ramalho,Guilherme Macedo +5 more
Journal ArticleDOI
Worrisome Trends in Young-Onset Colorectal Cancer: Now Is the Time for Action
Gaurav I. Patel,P J Patil +1 more
TL;DR: Key aspects related to colorectal cancer in young adults are provided, including epidemiology, etiology, genetics, clinical difficulties, early diagnosis, and prevention with emphasis on screening age.
References
More filters
Journal ArticleDOI
Cancer statistics, 2018
TL;DR: The combined cancer death rate dropped continuously from 1991 to 2015 by a total of 26%, translating to approximately 2,378,600 fewer cancer deaths than would have been expected if death rates had remained at their peak.
Journal ArticleDOI
GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables
Gordon H. Guyatt,Andrew D Oxman,Elie A. Akl,Regina Kunz,Gunn Elisabeth Vist,Jan Brozek,Susan L Norris,Yngve Falck-Ytter,Paul Glasziou,Hans deBeer,Roman Jaeschke,David Rind,Joerg J Meerpohl,Philipp Dahm,Holger J. Schünemann +14 more
TL;DR: The GRADE process begins with asking an explicit question, including specification of all important outcomes, and provides explicit criteria for rating the quality of evidence that include study design, risk of bias, imprecision, inconsistency, indirectness, and magnitude of effect.
Journal ArticleDOI
Colorectal cancer statistics, 2017.
Rebecca L. Siegel,Kimberly D. Miller,Stacey A. Fedewa,Dennis J. Ahnen,Reinier G.S. Meester,Afsaneh Barzi,Ahmedin Jemal +6 more
TL;DR: Overall CRC incidence in individuals ages ≥50 years declined from 2009 to 2013 in every state except Arkansas, with the decrease exceeding 5% annually in 7 states; however, rectal tumor incidence in those ages 50 to 64 years was stable in most states.
Book
Health Risks from Exposure to Low Levels of Ionizing Radiation:: BEIR VII Phase 2
TL;DR: Health risks from exposure to low levels of ionizing radiation : BEIR VII Phase 2 , Health risks from Exposure to low Levels of Ionizing radiation: BEIR VIII Phase 2, شاپور اهواز.
Journal ArticleDOI
Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement
Kirsten Bibbins-Domingo,David C. Grossman,Susan J. Curry,Karina W. Davidson,John W. Epling,Francisco A.R. Garcia,Matthew W. Gillman,Diane M. Harper,Alex R. Kemper,Alex H. Krist,Ann E. Kurth,C. Seth Landefeld,Carol M. Mangione,Douglas K Owens,Douglas K Owens,William R. Phillips,Maureen G. Phipps,Michael Pignone,Albert L. Siu,Albert L. Siu +19 more
TL;DR: It is concluded with high certainty that screening for colorectal cancer in average-risk, asymptomatic adults aged 50 to 75 years is of substantial net benefit.
Related Papers (5)
Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement
Kirsten Bibbins-Domingo,David C. Grossman,Susan J. Curry,Karina W. Davidson,John W. Epling,Francisco A.R. Garcia,Matthew W. Gillman,Diane M. Harper,Alex R. Kemper,Alex H. Krist,Ann E. Kurth,C. Seth Landefeld,Carol M. Mangione,Douglas K Owens,Douglas K Owens,William R. Phillips,Maureen G. Phipps,Michael Pignone,Albert L. Siu,Albert L. Siu +19 more